Founded in Union City, CA, XII Medical is dedicated to developing minimally invasive outpatient technologies for the treatment of obstructive sleep apnea (OSA). The company's core mission is to transform neuromodulation therapies to simplify OSA treatment, expand patient access, and improve clinical outcomes. XII Medical focuses on creating best-in-class medical devices that offer effective and accessible solutions for individuals suffering from this common yet serious sleep disorder.
XII Medical has garnered attention for its innovative approach to OSA treatment, attracting notable investors and industry experts. The company has achieved significant milestones in the development and clinical testing of its devices, positioning itself as a leader in the medical device sector for sleep apnea. By improving patient outcomes and making treatment more accessible, XII Medical has made a substantial impact on the healthcare landscape for sleep disorders.
